OPTION AND LICENSE AGREEMENTOption and License Agreement • June 17th, 2016 • Cempra, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 17th, 2016 Company Industry JurisdictionThis OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 29, 2016 (the “Effective Date”) by and between Cempra Pharmaceuticals, Inc., a Delaware corporation having an address at 6320 Quadrangle Dr. #360, Chapel Hill, NC 27517 (“Cempra”), and Macrolide Pharmaceuticals, Inc., a Delaware corporation having an address at 480 Arsenal St., Suite 130, Watertown, MA 02472 (“MP”). MP and Cempra may be referred to herein individually as a “Party” or collectively, as the “Parties.”
Option and License AgreementOption and License Agreement • February 25th, 2016 • Cempra, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 25th, 2016 Company Industry JurisdictionThis Option and License Agreement (the “Agreement”) is entered into as of January 29, 2016 (the “Effective Date”) by and between Cempra Pharmaceuticals, Inc., a Delaware corporation having an address at 6320 Quadrangle Dr. #360, Chapel Hill, NC 27517 (“Cempra”), and Macrolide Pharmaceuticals, Inc., a Delaware corporation having an address at 480 Arsenal St., Suite 130, Watertown, MA 02472 (“MP”). MP and Cempra may be referred to herein individually as a “Party” or collectively, as the “Parties.”